deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02251041

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL) (CAPITL)

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL): a First-in-men Study

Sponsor: Universitaire Ziekenhuizen KU Leuven

Conditions Reperfusion Injury
Interventions Alfa-tocopherol Antithrombin-III Apotransferrin C1-Inhibitor Epoprostenol Glutathione Human recombinant erythropoietin Infliximab Melatonin Sodium chloride solution
Updated 8 times since 2017 Last updated: Apr 2, 2024 Started: Sep 30, 2014 Primary completion: Feb 28, 2019 Completion: Aug 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Reperfusion Injury and is currently completed. Universitaire Ziekenhuizen KU Leuven leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotUnknown Status~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotCompleted~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Nov 2022 [monthly]

    Completed PHASE2

  5. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2019 [monthly]

    Unknown Status PHASE2

  2. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  3. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universitaire Ziekenhuizen KU Leuven
Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations